Rx News Connection: May 2022
In the medical arena, information changes quickly. What was irrelevant yesterday, may be paramount today. PharmCon’s News Connection series seeks to distill the most impactful news for health professionals from the vast sea of news that confronts us all, then bridge the gap between the immediacy of those critical items and the delay that occurs as that information is incorporated into more focused programming. Our team of skilled editors continually scans the emerging medical news to bring the most relevant pieces to the forefront and deliver them to you in a concise, practical manner. In this session, we investigate timely items, including: New Heart Failure Guidelines, New FDA Approvals, Olaparib Approved for High-Risk Early Breast Cancer, SARS-CoV-2 Omicron Sub-variant BA.2, Brain Changes in COVID-19 Survivors, and Diabetes Risk in COVID-19 Survivors.